---
schema_version: "secwatch.filing_event.v1"
accession: "0001764013-26-000106"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2026-09-03T21:05:38+00:00"
generated_at: "2026-09-03T21:08:45.247123+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Immunovant annual meeting: directors elected, E&Y ratified, say-on-pay approved

## Summary
- 198,373,370 shares represented (~96% of eligible) at Sept 2, 2026 annual meeting.
- Directors Bauer, Hughes, Susman elected with 162.9M, 174.1M, 181.6M votes for, respectively.
- Ernst & Young ratified as independent auditor for FY ending March 31, 2027 (198.1M for).
- Non-binding say-on-pay approved: 180.8M for, 8.4M against, 91.9K abstain.

## SEC filing metadata
- accession: 0001764013-26-000106
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2026-09-03T21:05:38+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000176401326000106/0001764013-26-000106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000176401326000106/imvt-20260902.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764013-26-000106
- JSON: https://secwatch.observer/filing/0001764013-26-000106.json
- Plain text: https://secwatch.observer/filing/0001764013-26-000106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.